亚康股份 reported revenue of ¥0.83B for the period ended 2026-06-30, +36.9% year on year. Net income was ¥0.05B, a 5.9% net margin on a 16.9% gross margin. The largest revenue line is 算力设备集成销售业务 at 34% of the total. Free cash flow for the period was ¥0.21B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.83B | +36.9% |
| Gross profit | ¥0.14B | — |
| Operating income | ¥0.06B | — |
| Net income | ¥0.05B | +173.6% |
| Gross margin | 16.9% | Net margin 5.9% |
| Revenue Q/Q | +29.1% | — |
| Segment | Revenue | Share |
|---|---|---|
| 算力设备集成销售业务 | ¥0.28B | 34.0% |
| 算力基础设施综合服务-驻场运维服务 | ¥0.25B | 30.4% |
| 算力基础设施综合服务-交付实施服务 | ¥0.15B | 18.1% |
| 数字化增值解决方案服务 | ¥0.08B | 9.3% |
| 算力基础设施综合服务-售后维保服务 | ¥0.07B | 8.1% |
| 其他(补充) | ¥0.00B | 0.0% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.69B | 83.1% |
| R&D | ¥0.02B | 2.1% |
| SG&A | ¥0.04B | 4.8% |
| Tax & other | ¥0.01B | 0.9% |
| Item | Amount |
|---|---|
| Total assets | ¥1.74B |
| Total liabilities | ¥0.77B |
| Shareholders' equity | ¥0.97B |
| Equity / assets | 55.8% |
| Operating cash flow | ¥0.21B |
| Capital expenditure | ¥0.01B |
| Free cash flow | ¥0.21B |
| Cash conversion (OCF / net income) | 260% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
鸿富瀚 ・ 可孚医疗 ・ 戎美股份 ・ 拓新药业 ・ 华润材料 ・ 深城交 ・ 争光股份 ・ 华兰股份 ・ 广立微 ・ 百诚医药 ・ 天益医疗 ・ 金埔园林
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies